COVID-19 SIG Lecture Series Archive

COVID Lecture: SARS-CoV-2: What We Have Learned So Far
Yoshi Kawaoka, PhD., University of Wisconsin and University of Tokyo
May 26, 2022

The Mystery of Central Nervous System Complications of COVID-19: What Do We Know and What Do We Need to Learn?
Serena Spudich, MD, MA, Yale
March 17, 2022

Age, time, and treatment-related immunopathological signatures in pediatric COVID-19 and MIS-C
Luigi Notarangelo, MD, NIH
March 3, 2022

Antivirals for Coronaviruses: Mechanism, Resistance, and Regulation
Mark Denison, MD, Vanderbilt
February 17, 2022

SARS-CoV-2 Evolution and Potential Variant Emergence in Immunocompromised Individuals
Veronique Nussenblatt, MD and Elodie Ghedin, PhD., NIH
February 3, 2022

Heterologous Prime/Boost Covid-19 Vaccine Schedules Emerging Data From the COM-COV and COM-Boost Studies
Matthew Snape MBBS, FRCPCH, MD, University of Oxford
January 20, 2022

COVID-19 Two Years Later—The Impact on Research and Public Health in Diverse Communities
Diversity Round Table (NIAID/DMID Diversity Series) moderated by Shannon N. Zenk, Ph.D., MPH, RN, FAAN, NIH
January 13, 2022

New Approaches to Detect, Study and Treat SARS-CoV-2 Infection
Melanie Ott, MD, PhD., UCSF
January 6, 2022

COVID-19, International Law, and Data Governance
Alexandra Phelan, S.J.D., Georgetown University
December 16, 2021

Human Antibody Response to SARS-CoV-2 Infection and Vaccination
Michel Nussensweig, M.D., Ph.D., The Rockefeller University
December 2, 2021

Strategies for Development of Coronavirus Vaccines that Induce Broadly Reactive Neutralizing Antibodies
Barton F. Haynes, M.D., Duke Human Vaccine Institute
November 18, 2021

Acute Severe COVID-19 and Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
Adrienne G. Randolph, M.D., Boston Children’s Hospital, Harvard Medical School
November 4, 2021

New Insights into Coronavirus Emergence, Pathogenesis and Control
Ralph S. Baric M.D., The University of North Carolina at Chapel Hill
October 21, 2021

The Evolutionary Dynamics of SARS-CoV-2 Variants
Adi Stern Ph.D., Tel Aviv University
October 7, 2021

Lessons Learned from COVID-19: A 'Fireside Chat' with Dr. Anthony Fauci
Anthony Fauci, M.D., NIAID
June 17, 2021

Outbreak Response in the Genomic and Information Age
Pardis Sabeti, M.D., Ph.D., Broad Institute
June 3, 2021

Chasing SARS-CoV-2 Mutations Through Time and Space
Sharon Peacock, Ph.D., University of Cambridge
May 20, 2021

Health Disparities and SARS-CoV-2
Akilah Jefferson, M.D., Arkansas Children's Hospital
May 6, 2021

The Mental Health Impact of the COVID Pandemic: A Major Life Stressor
Naomi Simon, M.D., NYU Langone Health
April 15, 2021

SARS-CoV-2 and the VRC’s Structural Biology Section
Peter Kwong, Ph.D., NIAID VRC
April 1, 2021

Protective and Pathogenic B Cell Responses: COVID-19 and Autoimmunity
Ignacio Sanz, M.D., Emory University School of Medicine
March 18, 2021

Integrating Inflammation and Coagulation in COVID-19
Yogen Kanthi, M.D., NHLBI Lasker Scholar
March 4, 2021

The RECOVERY Trial: Science in a Crisis
Peter Horby, Ph.D., University of Oxford
February 18, 2021

COVID-19: Developing a Vaccine During a Pandemic
Dan Barouch, M.D., Ph.D., Harvard Medical School
February 4, 2021

COVID-19 Epidemiology and Transmission Dynamics: Contrasting South Africa, China and the US 
Cécile Viboud, Ph.D., NIH Fogarty International Center
January 21, 2021

Antiviral and Anti-inflammatory Approaches to COVID-19
John Beigel, M.D., NIAID
January 7, 2021

Genetic Studies Illuminating Pathways Important for Controlling COVID Disease
Helen Su, M.D., Ph.D., NIH NIAID
December 3, 2020

Harnessing Synthetic Biology and Deep Learning to Address the COVID-19 Pandemic (HHS-only)
Jim Collins, Ph.D., MIT
December 17, 2020.

Ethical Quandaries in the COVID-19 Pandemic
Christine Grady, M.S.N., Ph.D., NIH CC
November 19, 2020.

Immune Profiling to Understand COVID-19 Pathogenesis
John Wherry, Ph.D., University of Pennsylvania
November 5, 2020

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
Kizzmekia Corbett, Ph.D., NIH NIAID
October 15, 2020.

Neutralizing Antibodies to SARS-CoV-2
Paul Bieniasz, Ph.D., The Rockefeller University
October 1, 2020

SARS CoV2 T Cell Responses in Exposed and Non-Exposed Subjects
Alessandro Sette, La Jolla Institute for Immunology
July 29, 2020

Nucleic Acid Delivery Systems for RNA Therapy and Gene Editing
Dan Anderson, Ph.D.
Professor, Koch Institute for Integrative Cancer Research, MIT
July 15, 2020

Lessons Learned: Management and Treatment during COVID-19 Pandemic
Judith Aberg, M.D.
Chief, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai
July 8, 2020

High Seroprevalence, Drastic Decline of Incidence and Low Infection Fatality Rate of SARS-CoV-2 Infections in Children and Adults in the Ski Resort Ischgl, Austria
Dorothee von Laer, M.D.
Director, Division of Virology, Innsbruck Medical University
July 1, 2020

A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing
Nevan Krogan, Ph.D.
Director, Quantitative Bioscience Institute (QBI), University of California, San Francisco
June 24, 2020

COVID-19: The Australian Experience and a Perspective Through a SARS-1 Lens
Kanta Subbarao, M.B.B.S.
Director of the WHO Collaborating Centre for Reference and Research on Influenza, Doherty Institute
June 17, 2020

Toward Understanding COVID-19 Infection, Transmission, and Pathogenesis at Single-Cell Resolution with the Human Cell Atlas
Aviv Regev, Ph.D.
Director of the Klarman Cell Observatory and Cell Circuits Program at the Broad Institute
June 3, 2020

Structural Studies of Coronavirus Fusion Glycoproteins
David Veesler, Ph.D.
Assistant Professor of Biochemistry, University of Washington
May 27, 2020

Clinical Trials in Public Health Emergencies: The Ebola and COVID Experiences
Lori Dodd, Ph.D.
Mathematical Statistician, Biostatistics Research Branch, NIAID
May 13, 2020

Animal Models for COVID-19: A Critical Component of the Response to the Pandemic
Emmie de Wit, Ph.D.
Chief, Molecular Pathogenesis Unit, NIAID
May 6, 2020

COVID-19 Diagnostics: The Challenge of Rapid, High-Volume Detection of SARS-CoV-2
Karen Frank, M.D., Ph.D.
Chief, Department of Laboratory Medicine, Clinical Center
April 29, 2020

Rapid COVID-19 Vaccine Development: An Example of the Prototype Pathogen Approach for Pandemic Preparedness
Barney Graham, M.D., Ph.D.
Deputy Director, Vaccine Research Center, NIAID
April 22, 2020

The Biomedical Research Response to COVID-19: A View from NIAID
Hilary D. Marston, M.D., M.P.H.
Medical Officer, Policy Advisor for Global Health, NIAID
April 15, 2020

Content last reviewed on